Citations

Showing 10 of 108162 citations.

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
Sims, Emily K. , Bundy, Brian N. , Stier, Kenneth , Serti, Elisavet , Lim, Noha , Long, S. Alice , Geyer, Susan, Moran, Antoinette , Greenbaum, Carla J. , Evans‐Molina, Carmella , Group, Type 1 Diabetes TrialNet Study, DiMeglio, Linda A. , Gitelman, Stephen E. , Gottlieb, Peter A. , Marks, Jennifer B. , Moore, Wayne D. , Rodriguez, Henry , Russell, William E. , Schatz, Desmond , Wherrett, Diane K. , Ziegler, Anette‐Gabriele , Herold, Kevan C , DiMeglio, Linda , Group, Type 1 Diabetes TrialNet Study, Moore, Wayne, Tsalikian, Eva

Mayo Clinic

Science Translational Medicine | March 3, 2021 | Volume: 13 | Issue: 583 | Pages: No page available

10.1126/scitranslmed.abc8980 | PMID 33658358 Get It

Teplizumab treatment of nondiabetic relatives at high risk for T1D induces partially exhausted CD8 + T cells and improves beta cell function.
In Vitro Antibacterial Activity of Hydrogen Peroxide and Hypochlorous Acid, Including That Generated by Electrochemical Scaffolds
Raval, Yash S. , Flurin, Laure , Mohamed, Abdelrhman , Greenwood‐Quaintance, Kerryl E. , Patel, Robin , Patel, Robin , Mohamed, A , Beyenal, Haluk , Raval, Yash S.

Mayo Clinic

Antimicrobial Agents and Chemotherapy | March 3, 2021 | Volume: 65 | Issue: 5 | Pages: No page available

10.1128/aac.01966-20 | PMID 33649112 Get It

Hydrogen peroxide (H 2 O 2 ) and hypochlorous acid (HOCl) are biocides used for cleaning and debriding chronic wound infections, which often harbor drug-resistant bacteria. Here, we evaluated the in vitro activity of H 2 O 2 and HOCl against 27 isolates of eight bacterial species involved in wound infections.
Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations
Khanji, Mohammed Y , Galusko, Victor , Sekar, Baskar , Chahal, C. Anwar A. , Ceriello, Laura, Gallina, Sabina , Kennon, Simon, Ionescu, Adrian , Chahal, Choudhary Anwar A , Khanji, Mohammed Yunus , Ricci, Fabrizio , Awad, Wael Ibrahim

Mayo Clinic

European Heart Journal - Quality of Care and Clinical Outcomes | March 3, 2021 | Volume: 7 | Issue: 4 | Pages: 340-353

10.1093/ehjqcco/qcab016 | PMID 33751049 Get It

Abstract Multiple guidelines exist for the management of aortic stenosis (AS). We systematically reviewed current guidelines and recommendations, developed by national or international medical organizations, on management of AS to aid clinical decision-making. Publications in MEDLINE and EMBASE between 1 June 2010 and 15 January 2021 were identified. Additionally, the International Guideline Library, National Guideline Clearinghouse, National Library for Health Guidelines Finder, Canadian Medical Association Clinical Practice Guidelines Infobase, and websites of relevant organizations were searched. Two reviewers independently screened titles and abstracts. Two reviewers assessed rigour of guideline development and extracted the recommendations. Of the seven guidelines and recommendations retrieved, five showed considerable rigour of development. Those rigourously developed, agreed on the definition of severe AS and diverse haemodynamic phenotypes, indications and contraindications for intervention in symptomatic severe AS, surveillance intervals in asymptomatic severe AS, and the importance of multidisciplinary teams (MDTs) and shared decision-making. Discrepancies exist in age and surgical risk cut-offs for recommending surgical aortic valve replacement (SAVR) vs. transcatheter aortic valve implantation (TAVI), the use of biomarkers and complementary multimodality imaging for decision-making in asymptomatic patients and surveillance intervals for non-severe AS. Contemporary guidelines for AS management agree on the importance of MDT involvement and shared decision-making for individualized treatment and unanimously indicate valve replacement in severe, symptomatic AS. Discrepancies exist in thresholds for age and procedural risk used in choosing between SAVR and TAVI, role of biomarkers and complementary imaging modalities to define AS severity and risk of progression in asymptomatic patients.
Task‐specific efficient channel selection and bias management for Gabor function channelized Hotelling observer model for the assessment of x‐ray angiography system performance
Gomez‐Cardona, Daniel, Favazza, Christopher , Schueler, Beth A. , Fetterly, Kenneth A. , Favazza, Christopher P, Leng, Shuai

Mayo Clinic

Medical Physics | March 3, 2021 | Volume: 48 | Issue: 7 | Pages: 3638-3653

10.1002/mp.14813 | PMID 33656177 Get It

PurposeChannelized Hotelling observer (CHO) models have been implemented to assess imaging performance in x‐ray angiography systems. While current methods are appropriate for assessing unprocessed images of moving test objects upon uniform‐exposure backgrounds, they are inadequate for assessing conditions which more appropriately mimic clinical imaging conditions including the combination of moving test objects, complex anthropomorphic backgrounds, and image processing. In support of this broad goal, the purpose of this work was to develop theory and methods to automatically select a subset of task‐specific efficient Gabor channels from a task‐generic Gabor channel base set. Also, previously described theory and methods to manage detectability index (d′) bias due to nonrandom temporal variations in image electronic noise will be revisited herein.MethodsStarting with a base set of 96 Gabor channels, backward elimination of channels was used to automatically identify an “efficient” channel subset which reduced the number of channels retained in the subset while maintaining the magnitude of the d′ estimate. The concept of a pixelwise Hotelling observer (PHO) model was introduced and similarly implemented to assess the performance of the efficient‐channel CHO model. Bias in d′ estimates arising from temporally variable nonstationary noise was modeled as a bivariate probability density function for normal distributions, where one variable corresponds to the signal from the test object and the other variable corresponds to the signal from temporally variable nonstationary noise. Theory and methods were tested on uniform‐exposure unprocessed angiography images with detector target dose (DTD) of 6, 18, and 120 nGy containing static disk‐shaped test objects with diameter in the range of 0.5 to 4 mm.ResultsConsidering all DTD levels and test object sizes, the proposed method reduced the number of Gabor channels in the final subset by 63–82% compared to the original 96 Gabor channel base set, while maintaining a mean relative performance () of 95% 4% with respect to the reference PHO model. Experimental results demonstrated that the bivariate approach to account for bias due to temporally variable nonstationary noise resulted in improved correlation between the CHO and PHO models as compared to a previously proposed univariate approach.ConclusionsComputationally efficient backward elimination can be used to select an efficient subset of Gabor channels from an initial channel base set without substantially compromising the magnitude of the d′ estimate. Bias due to temporally variable nonstationary noise can be modeled through a bivariate approach leading to an improved unbiased estimate of d′.
Route of Hysterectomy for Benign Indications
Gebhart, John B.

Mayo Clinic

Journal of Gynecologic Surgery | March 3, 2021 | Volume: 37 | Issue: 2 | Pages: 98-100

10.1089/gyn.2021.0015 Get It

State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary
Epps, Quovadis J., Epps, Kevin , Young, David C. , Zobell, Jeffery T. , Epps, Kevin L

Mayo Clinic

Pediatric Pulmonology | March 3, 2021 | Volume: 56 | Issue: 7 | Pages: 1825-1837

10.1002/ppul.25353 | PMID 33656280 Get It

AbstractAcute pulmonary exacerbations are complications of cystic fibrosis (CF) and are associated with increased morbidity and mortality. Methicillin‐resistant Staphylococcus aureus (MRSA) and Aspergillus fumigatus are organisms that have been detected in the lungs of CF patients. The focus of this review is to provide an overview of the classes of antimicrobials used for MRSA and allergic bronchopulmonary aspergillosis (ABPA), a hypersensitivity reaction caused by A. fumigatus. The current anti‐MRSA antibiotics and medications for ABPA dosing recommendations are discussed. This article also reviews the findings from the MRSA utilization surveys and the pharmacokinetic and pharmacodynamic differences between CF and non‐CF patients. Antimethicillin S. aureus antibiotics include ceftaroline, clindamycin, fluoroquinolone derivatives (ciprofloxacin, levofloxacin), glycopeptide derivatives (telavancin, vancomycin), linezolid, rifampin, sulfamethoxazole/trimethoprim, and tetracycline derivatives (doxycycline, minocycline, tigecycline). Medications used for ABPA include corticosteroids, amphotericin B, azole antifungals (isavuconazole, itraconazole, posaconazole, voriconazole), and a monoclonal antibody, omalizumab.
Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients
McCain, Josiah D. , Chascsa, David M. , Lindor, Keith D.

Mayo Clinic

Expert Opinion on Orphan Drugs | March 3, 2021 | Volume: 9 | Issue: 2 | Pages: 53-66

10.1080/21678707.2021.1898370 Get It

Uncertainty at the Limits of Viability: A Qualitative Study of Antenatal Consultations
Kaemingk, Bethany D. , Carroll, Katherine , Thorvilson, Megan J. , Schaepe, Karen , Collura, Christopher A. , Schaepe, Karen S

Mayo Clinic

Pediatrics | March 3, 2021 | Volume: 147 | Issue: 4 | Pages: No page available

10.1542/peds.2020-1865 | PMID 33658319 Get It

BACKGROUND AND OBJECTIVES: Antenatal consultation between a neonatologist and expectant parent(s) may determine if resuscitation is provided for or withheld from neonates born in the gray zone of viability. In this study, we sought to gain a deeper understanding of uncertainties present and neonatologists’ communication strategies regarding such uncertainties in this shared decision-making. METHODS: A prospective, qualitative study using transcriptions of audio-recorded antenatal consultations between a neonatologist and expectant parent(s) was conducted. Pregnant women were eligible if anticipating delivery in the gray zone of viability (22 0/7–24 6/7 weeks’ gestation). Over 18 months, 25 of 28 pregnant women approached consented to participate. Applied thematic analysis was used to inductively derive and examine conceptual themes. RESULTS: Inductive analysis of consult transcripts revealed uncertainty as a central theme. Several subthemes relating to uncertainty were also derived, including the timing of delivery, NICU course, individual characteristics (of physician, expectant parent(s), and fetus or neonate), and consequences of the decision for the expectant parent(s). Analysis revealed that uncertainty was actively managed by neonatologists through a variety of strategies, including providing more information, acknowledging the limits of medicine, acknowledging and accepting uncertainty, holding hope, and relationship building. CONCLUSIONS: Uncertainty is pervasive within the antenatal consultation for periviable neonates and likely plays a significant role in decision-making toward postnatal resuscitative efforts. Uncertainty complicated, or even paralyzed, decision-making efforts while also providing reassurance toward a positive outcome. Directions for future study should consider whether advanced communication training modulates the impact that uncertainty plays in the shared decision-making encounter.
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel
Melody, Megan , Gandhi, Sangeetha, Rahman, Zaid Abdel , Lengerke-Diaz, Paula A. , Gannon, Nicole, Truong, Tuan, Brandes, Eva, Lange, Gina, Estby, Breana, Johnston, Patrick B. , Ansell, S., Ayala, Ernesto , Murthy, Hemant S. , Foran, James M. , Castro, Januario E. , Lin, Yi , Kharfan‐Dabaja, Mohamed A. , Rahman, Zaid H. Abdel , Lengerke-Diaz, Paula, Novo, Mattia , Ansell, Steve, Bennani, N Nora , Tun, Han W. , Castro, Januario, Kharfan-Dabaja, Mohamed A , Murthy, Hemant S , Abdel Rahman, Zaid H , Castro, Januario E , Lin, Yi , Diaz, Paula A Lengerke , Rosenthal, Allison , Bennani, N. Nora , Paludo, Jonas , Villasboas, José C. , Roy, Vivek

Mayo Clinic

European Journal of Haematology | March 3, 2021 | Volume: 107 | Issue: 1 | Pages: 48-53

10.1111/ejh.13609 | PMID 33655560 Get It

AbstractIntroductionHypoalbuminemia is a known adverse prognostic factor in lymphomas. Yet, it is unknown if axicabtagene ciloleucel (axi‐cel) overcomes the adverse prognostic impact of hypoalbuminemia in relapsed/refractory large B‐cell lymphoma.MethodsWe conducted a retrospective analysis across three Mayo Clinic centers to assess the relationship of hypoalbuminemia (defined as a serum albumin (SA) levels ≤ 3.5 g/dL) on outcomes of patients treated with axi‐cel.ResultsThis analysis included 81 patients. Two patients had no available SA levels preceding axi‐cel infusion. Eighteen patients (22.8%) had hypoalbuminemia with a median SA of 3.3 g/dL. Patients with normal SA had a statistically higher ORR than those without hypoalbuminemia (P = .018). There was no difference in 1‐year PFS and OS between the group with hypoalbuminemia and the group with normal SA levels (48% vs 49%, P = .81) and (74% vs 73%, P = .97), respectively. There was no difference in the severity or median duration of cytokine release syndrome or neurotoxicity between the two groups.ConclusionNotwithstanding the limitations related to the relatively small sample size, axi‐cel therapy appears to overcome the adverse effect of hypoalbuminemia on OS and PFS. Large multicenter clinical studies are certainly needed to validate these findings.
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review
Karmacharya, Paras , Ogdie, Alexis , Karmacharya, Paras , Ogdie, Alexis , Eder, Lihi

Mayo Clinic

Therapeutic Advances in Musculoskeletal Disease | March 3, 2021 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/1759720x21998279 | PMID 33737966 Get It

Psoriatic arthritis (PsA) is associated with a higher burden of cardiometabolic disorders, such as hypertension, dyslipidemia, diabetes, obesity, and cardiovascular disease (CVD), compared with the general population. These comorbidities are associated with the severity of disease, and adversely affect treatment outcomes in PsA. Comorbidities lead to increased physician visits and medications for patients and make the selection and maintenance of therapies challenging for physicians. Moreover, CVD is a leading cause of mortality in PsA. Therefore, optimal management of PsA should include not only treating the skin and joint disease, but also identifying comorbidities early, and managing them to improve long-term outcomes. Further studies are needed to understand the complex mechanisms, interactions, and trajectories of cardiometabolic comorbidities in psoriatic disease. Plain Language Summary Psoriatic arthritis and the association with cardiometabolic disease Psoriatic arthritis (PsA) is associated with a higher incidence and prevalence of cardiometabolic comorbidities compared with the general population, and higher than psoriasis and other inflammatory arthritides, such as rheumatoid arthritis and other spondyloarthritides. Obesity and hyperlipidemia are associated with an increased risk of developing PsA. Cardiometabolic comorbidities in PsA are associated with more severe disease and a lower likelihood of response to therapy. Suggested approaches to improve screening and management of CVD in PsA include education of family physicians and relevant specialists, development of mechanisms to improve communication between the rheumatologists and primary care providers, and novel models of care, including interdisciplinary cardio-rheumatology clinics.